Quantcast

Latest Intarcia Therapeutics Inc. Stories

2015-05-15 16:24:49

- CEO Kurt Graves interviewed by Jim Cramer on CNBC's "Mad Money" as one of the companies named to the important list of "Disruptors" BOSTON, May 15, 2015 /PRNewswire/ --

2015-05-04 08:30:00

- New Chief Operating Officer position has full accountability for taking the lead in building out novel go-to-market model, commercial capabilities and operational plans for ITCA 650.

2015-05-01 16:31:34

- New role increases Company's ability to drive optimal performance through people strategy, organizational effectiveness, learning & development, and a values-based work environment -

2015-04-28 00:23:14

- Company secures $225M financing in exchange for 1.5% of future global net sales of ITCA 650, a novel once or twice yearly and injection-free GLP-1 therapy currently in phase 3 clinical development

2015-03-19 16:29:53

-- Collaboration combines Intarcia's proprietary delivery technologies with Numab's novel multi-specific antibody technology to broaden and strengthen Intarcia's pipeline BOSTON and

2014-11-12 00:21:49

- Intarcia grants Servier exclusive rights to ITCA 650 in ex-U.S./Japan territories; Intarcia retains full control of ITCA 650 in the United States and plans another partner in Japan.

2014-10-02 00:21:35

-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications.

2014-09-19 08:25:27

-- Patients treated with ITCA 650 for 6 months showed an average HbA1c reduction of -3.2% at the time of the interim analysis; patients at baseline had HbA1c greater than or equal to 10% to 12%. VIENNA,

2014-09-17 08:29:46

- Data indicate 58% non-adherence to second-line treatments in T2D patients, significantly higher than patients report and prescribers perceive VIENNA, Sept.

2014-09-11 16:28:19

- Oral presentation 9/19: interim Phase 3 results for ITCA 650 among patients with high baseline (HBL) HbA1c levels between 10-12% showed dramatic HbA1c reductions, even in patients with high HbA1c


Word of the Day
logocentrism
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.
Related